© 2018 RSM US LLP. All rights reserved.
Capabilities
Across the United States, from the East Coast’s biotech corridor to California’s Bay Area, RSM has developed a cross-functional team of specialists focused on helping life sciences organizations like yours navigate the challenges of the industry. Our clients include local, national and international companies with diverse organizational structures. The segments we serve include:
- Pharmaceuticals
- Biotechnology
- Medical device companies
- Contract manufacturing organizations
- Clinical research organizations
- Other companies that support the life sciences industry
We work with life sciences companies at all stages, assisting with deals, tax strategies, industry-specific accounting, and technology to support commercialization and initial public offerings. We can provide solutions on a scale that’s right for your business today, and through our national and international reach we can offer the resources to take your business into the future. We provide the following to our life sciences clients:
Audit services
Our audits focus on key risks for life sciences organizations. Our experienced audit professionals are versed in financial reporting complexities applicable to life sciences businesses, including:
- Revenue recognition
- In-licensing and out-licensing issues
- Recognition of nonrefundable, upfront licenses and other fees
- Reporting revenue gross vs. net
- Multiple element arrangements
- Debt and equity transaction accounting
- Accounting for business combinations
- Acquisition of in-process research and development
- Timing of recognition for contracted research and development activities
Tax services
Our tax professionals take a holistic approach to understanding a business’s overall needs and offer knowledgeable advice tailored to the business’s unique tax profile. In addition, we help life sciences businesses identify opportunities to minimize tax and compliance burdens related to:
- Federal, state and international tax compliance and planning
- Intellectual property planning
- Transfer pricing
- Federal and state research and development tax credit calculations
- Mergers and acquisitions
- Tax attribute analyses
- Section 382 change in ownership studies
- Valued added tax (VAT)
Consulting services
RSM’s business consultants provide a comprehensive range of services in the areas of financial advisory, operations, risk management and information technology. We create customized approaches based on your needs. Our consulting services include the following:
Risk advisory
- Enterprise risk management
- Anti-corruption consulting
- Sarbanes-Oxley advisory services
- Internal audit outsourcing and co-sourcing
- Royalty licenses and contract compliance audits
- Security and privacy consulting
- Information technology risk consulting
- Service organization assurance and consulting services
Financial advisory
- Transaction advisory (buy- and sell-side due diligence)
- Divestitures and carve-outs
- Valuation
- Litigation and dispute advisory
- Forensic accounting and fraud investigations
Technology and management consulting
- Management consulting
- Operational excellence, strategy design and business process improvement
- Merger integration and carve-outs
- Software selection and optimization
- Project, program and change management
- Corporate performance management and business analytics
- Business applications
- Enterprise resource planning and customer relationship management
- Business intelligence
- Cloud computing
- Managed services
- Finance and accounting outsourcing
- Infrastructure, applications and help desk
Life Sciences Insights
Contact Our Team
John Lanza
National Life Sciences Practice Leader
800.274.3978
John.Lanza@rsmus.com
EVENTS / WEBCASTS
IN-PERSON EVENT
Healthcare and Life Sciences Private Equity and Finance Conference
Healthcare-focused private equity, lending and finance conference will explore ways to successfully close transactions and achieve growth.
RECORDED WEBCAST
What does the Tax Cuts and Jobs Act mean for life sciences companies?
This recorded webcast provides an overview of the key provisions of the new tax bill and how they affect life sciences companies.
ON DEMAND WEBCAST
Revenue recognition: Key considerations for the life sciences industry
View this webcast to learn how the new revenue recognition standard (ASC 606) affects the life sciences industry (CPE eligible).